AniCell Biotech Launches EquusCell Product Line of Regenerative Therapies
CONTACT: Tammi Jacobs
Phone: 480.477.0100
AniCell Biotech launches the EquusCell product line of regenerative therapies for horses that requires no harvesting of bone marrow or fat stem cells.
CHANDLER, AZ, October 5, 2015 – AniCell Biotech launched the EquusCell Brand of regenerative products used for treating tendon and ligament damage as well as treating hard-to-heal superficial and ocular wounds. This product line does not require invasive harvesting or culturing of bone marrow or adipose tissue stem cells to treat injuries in horses. It uses mesenchymal stem cell components from amniotic material collected non-invasively during the parturition of healthy foals to produce these all-natural, minimally manipulated regenerative products.
Dr. Lauren Schnabel DACVS, PhD, DACVSMR, veterinary surgeon and internationally recognized research scientist of stem cell therapies in horses at North Carolina State University said, “I have been extremely impressed with the StemWrap and AlloMatrix products for the treatment of complicated wounds, including those over joints. These products accelerate healing and promote the formation of healthy granulation tissue. They are also well packaged and easy to use
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.

Related Articles
Stay on top of the most recent Horse Health news with